is compound tirzepatide going away Away? Here's a Pro Tip to Stay On It Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

All products on this site are intended for research and development purposes only and are not meant for human consumption of any kind

It is not for human consumption, medical, or veterinary use

Wegovy is approved for adults with: Obesity (BMI 30), or Overweight (BMI 27) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol

Combining hormone replacement therapy (HRT) patches with weight loss medications requires careful medical planning

BioMed Research International , 2015, 648108

Weight loss was still ongoing at week 48, suggesting potential for even greater results with longer treatment